Table 3.
t1/2 | tmax | Cmax | AUC0–∞ | Cl/F | |
---|---|---|---|---|---|
(hr) | (hr) | (ng × mL−1) | (ng × mL−1 × hr) | (L × hr−1) | |
R-bupropion | 17.6±5.9 | 1.0 | 68.5±16.5 | 322.9±114.0 | 169.0±61.2 |
S-bupropion | 13.9±9.2 | 1.5 | 11.6±2.3 | 56.0±26.3 | 1112±702 |
(2R,3R)-4-hydroxybupropion | 23.3±1.9 | 2.0 | 276.0±157 | 10148±5408 | - |
(2S,3S)-4-hydroxybupropion | 15.7±2.2 | 2.0 | 11.5±6.7 | 233±194 | - |
Erythro-dihydrobupropion A | 31.7±5.4 | 4 | 8.7±3.0 | 433±157 | - |
Erythro-dihydrobupropion B | 22.4±4.6 | 2.0 | 3.8±2.0 | 75.4±35.1 | - |
Threo-dihydrobupropion A | 59.9±25.9 | 6 | 20.6±4.9 | 2038±1323 | - |
Threo-dihydrobupropion B | 9.8±2.7 | 1.5 | 55.1±237.2 | 124.8±80.6 | - |